Publications by authors named "Farshad Zohrabi"

Background: In this study, we sought to identify the clinical baseline characteristics and pre-therapy 68Ga-PSMA PET derived parameters that can have impact on PSA (biochemical) response, OS and PSA PFS in patients with metastatic castration-resistant prostate cancer (mCRPC) who undergo RLT with [177Lu]Lu-PSMA-617.

Methods: Various pre-treatment clinical and PSMA PET derived parameters were gathered and computed. We used PSA response as the criteria for more than a 50% decrease in PSA level, and OS and PSA PFS as endpoints.

View Article and Find Full Text PDF

Background: Bladder cancer (BC) is the 10th most common type of cancer worldwide and the fourth most common type of cancer in Iran. Opium use is considered as one of the risk factors for BC. We aim to assess the association between various parameters of opium use, which in Iran is mainly ingested or smoked in various forms, and the risk of BC.

View Article and Find Full Text PDF

In recent years, lutetium-177 (Lu)-labeled prostate-specific membrane antigen (PSMA)-617 has become a promising new therapeutic agent in patients with metastatic castration-resistant prostate cancer (mCRPC). In this study, we report on an early experience of Lu-PSMA therapy with an evaluation of its efficacy and safety in mCRPC patients. Twenty-one mCRPC patients with a mean age of 70.

View Article and Find Full Text PDF

Soil contamination by petroleum compounds threatens the health of soil and water resources. This research was conducted with the objective of reaching an efficient technique for the removal or reduction of harmful effects caused by total petroleum hydrocarbons (TPH) in soils. In a greenhouse experiment, the effect of biochar (B), mycorrhizae (M) and combination of mycorrhizae and biochar (M + B) on the growth of two native species; clover (Trifolium arvense) and mallow (Malva sylvestris L.

View Article and Find Full Text PDF

We presented a promising result of radionuclide therapy using Lu-PSMA and Lu-DOTATATE in a patient with prostatic adenocarcinoma and neuroendocrine differentiation. Functional imaging of somatostatin receptors in patients with metastatic castration-resistant prostate cancer may pave the way toward implementation of novel radionuclide targets for the treatment of this aggressive subtype of prostate cancer.

View Article and Find Full Text PDF

Purpose: This clinical study evaluated the effect of autologous muscle-derived cell (MDC) injection for the treat-ment of female patients with pure stress urinary incontinence (SUI).

Materials And Methods: A total of 20 women with SUI received transurethral injections of autologous MDCs. Baseline and follow-up evaluations consisted of physical examinations (cough stress tests), one-hour pad test, In-continence Impact Questionnaire-7 (IIQ-7), and Urogenital Distress Inventory (UDI-6) scoring.

View Article and Find Full Text PDF